Classification performance testing on the third AD blood expression dataset was acceptable (GSE140829AD, AUC 72%, data not shown), while classification within PD and FRDA was less than acceptable for PD1 (AUC 64%), PD2 (AUC 68%), and FRDA (AUC 64%) (Figure 3b). Here, PAF1 is linked to Alzheimer disease.